Technical data sheets, safety documentation, regulatory reference files, and evaluation samples (50–100g) are available at no charge to qualified R&D laboratories and formulation OEMs. No purchase commitment required.
Manufactured under Japanese Quasi-Drug Raw Material standards with complete lot traceability and certificate of analysis for every batch.
Both Hydroxyapatite-LC and general mineral-derived HAP start from limestone. The difference is everything that happens after — and it determines whether the material performs in a formulation claim or just appears on an ingredient list.
The critical difference lies not in the source rock, but in the precision of the manufacturing process and the purpose of the design. General industrial HAP is engineered for bulk application; Hydroxyapatite-LC is specifically designed and tested for cosmetic and oral care performance claims.
Full physical and chemical specifications, particle size data, solubility, pH in suspension, bulk density, and formulation compatibility parameters.
Available on requestGHS-compliant safety data sheet documenting hazard classification (non-hazardous), handling requirements, first aid, and disposal information.
Available on requestLot-specific CoA confirming purity, particle size distribution, heavy metal limits, and quality parameter compliance for manufacturing batch traceability.
Per lot — on requestSummary of regulatory status across key markets: Japan (Quasi-Drug), EU (SCCS assessment reference), and relevant INCI documentation for formulation dossiers.
Available on requestCurated reference list of peer-reviewed publications covering remineralisation, bacterial adsorption, sensitivity reduction, and whitening efficacy — with relevance notes per application pillar.
Available on requestPhysical powder sample for in-house formulation testing, stability assessment, and sensory evaluation. Shipped to qualified R&D laboratories. No purchase commitment required for evaluation.
Qualified labs — on request